Literature DB >> 21945607

Evaluation of red blood cell labelling methods based on a statistical model for red blood cell survival.

Julia Korell1, Carolyn V Coulter, Stephen B Duffull.   

Abstract

The aim of this work is to compare different labelling methods that are commonly used to estimate the lifespan of red blood cells (RBCs), e.g. in anaemia of renal failure, where the effect of treatment with erythropoietin depends on the lifespan of RBCs. A previously developed model for the survival time of RBCs that accounts for plausible physiological processes of RBC destruction was used to simulate ideal random and cohort labelling methods for RBCs, as well as the flaws associated with these methods (e.g. reuse of label and loss of the label from the surviving RBCs). Random labelling with radioactive chromium and cohort labelling using heavy nitrogen were considered. Blood sampling times were determined for RBC survival studies using both labelling methods by applying the theory of optimal design. It was assessed whether the underlying parameter values of the model are estimable from these studies, and the precision of the parameter estimates were calculated. In theory, parameter estimation would be possible for both types of ideal labelling methods without flaws. However, flaws associated with random labelling are significant and not all parameters controlling RBC survival in the model can be estimated with good precision. In contrast, cohort labelling shows good precision in the parameter estimates even in the presence of reuse and prolonged incorporation of the label. A model based analysis of RBC survival studies is recommended in future to account for limitations in methodology as well as likely causes of RBC destruction.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21945607     DOI: 10.1016/j.jtbi.2011.09.016

Source DB:  PubMed          Journal:  J Theor Biol        ISSN: 0022-5193            Impact factor:   2.691


  7 in total

1.  Modeling red blood cell survival data.

Authors:  Julia Korell; Frederiek E Vos; Carolyn V Coulter; John B Schollum; Robert J Walker; Stephen B Duffull
Journal:  J Pharmacokinet Pharmacodyn       Date:  2011-10-14       Impact factor: 2.745

2.  A semi-mechanistic red blood cell survival model provides some insight into red blood cell destruction mechanisms.

Authors:  Julia Korell; Stephen B Duffull
Journal:  J Pharmacokinet Pharmacodyn       Date:  2013-06-18       Impact factor: 2.745

3.  Age-structured population model of cell survival.

Authors:  Wojciech Krzyzanski; Pawel Wiczling; Asfiha Gebre
Journal:  J Pharmacokinet Pharmacodyn       Date:  2017-03-29       Impact factor: 2.745

Review 4.  The Chemical Scaffold of Theranostic Radiopharmaceuticals: Radionuclide, Bifunctional Chelator, and Pharmacokinetics Modifying Linker.

Authors:  Holis Abdul Holik; Faisal Maulana Ibrahim; Angela Alysia Elaine; Bernap Dwi Putra; Arifudin Achmad; Achmad Hussein Sundawa Kartamihardja
Journal:  Molecules       Date:  2022-05-10       Impact factor: 4.927

5.  Models for the red blood cell lifespan.

Authors:  Rajiv P Shrestha; Joseph Horowitz; Christopher V Hollot; Michael J Germain; John A Widness; Donald M Mock; Peter Veng-Pedersen; Yossi Chait
Journal:  J Pharmacokinet Pharmacodyn       Date:  2016-04-02       Impact factor: 2.745

6.  Mathematical modeling of erythrocyte chimerism informs genetic intervention strategies for sickle cell disease.

Authors:  Philipp M Altrock; Christian Brendel; Raffaele Renella; Stuart H Orkin; David A Williams; Franziska Michor
Journal:  Am J Hematol       Date:  2016-07-14       Impact factor: 10.047

7.  Shortened red blood cell age in patients with end-stage renal disease who were receiving haemodialysis: a cross-sectional study.

Authors:  Koichiro Matsumura; Toshika Okumiya; Tetsuro Sugiura; Nobuyuki Takahashi; Yoshihiro Yamamoto; Sanae Kikuchi; Kenichi Fujii; Munemitsu Otagaki; Ichiro Shiojima
Journal:  BMC Nephrol       Date:  2020-09-29       Impact factor: 2.388

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.